The importance of beta blockers in the treatment of heart failure

American Family Physician

Volumn 62, Issue 11, 2000, Pages 2453-2462

  Chavey II, William E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BISOPROLOL FUMARATE; BUCINDOLOL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; METOPROLOL TARTRATE; SPIRONOLACTONE;

CLINICAL TRIAL; DOSE CALCULATION; DOSE RESPONSE; DRUG APPROVAL; DRUG CHOICE; DRUG LABELING; DRUG SAFETY; HEART FAILURE; HEMODYNAMICS; HUMAN; META ANALYSIS; PATIENT MONITORING; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; BISOPROLOL; CARBAZOLES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; METOPROLOL; PATIENT SELECTION; PROPANOLAMINES; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX;

EID: 0034405698     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)
2. Heart failure: A growing public health problem
3. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management
4. Trends in acute myocardial infarction and coronary heart disease death in the United States
5. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
6. Survival after the onset of congestive heart failure in Framingham Heart Study subjects
7. Economic impact of heart failure in the United States: Time for a different approach
8. National Ambulatory Medical Care Survey: 1989 Summary
9. Differences between primary care physicians and cardiologists in management of congestive heart failure: Relation to practice guidelines
10. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
11. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
12. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
13. The effect of spironoiactone on morbidity and mortality in patients with severe heart failure
14. Prognostic value of plasma endothelin-1 in patients with chronic heart failure
15. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
16. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
17. Hormones and hemodynamics in heart failure
18. A randomized trial of beta-blockade in heart failure
19. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
20. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
21. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure
22. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
23. Safety and efficacy of carvedilol in severe heart failure
24. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
25. Carvedilol trial in severe heart failure stopped early; Drug has significant mortality benefits over placebo
26. Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee
27. Beta-blocker not BEST for African-American patients with advanced CHF
28. Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled trials